Release Date: 30/08/13 11:04 Summary: Appendix 4E June 2013 Price Sensitive: Yes Download Document 446.01KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%